10 February 2021 |

MedLumics closes upsized 18M€ financing round

MADRID, FEBRUARY 10th 2021 – MedLumics, a privately held medical device company developing AblaView, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board of Directors. MedLumics’ optical catheter displays

20 March 2017 |

Innogest invests in MedLumics, €34m Series B Round closed

MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today the largest round in the history of medtech in Spain and one of the largest in Europe this year. Led by Edmond de Rothschild Investment Partners (EdRIP), the Series B round included funding from new investors Seroba Life Sciences, Innogest Capital, as well as from existing investors Ysios Capital Partners and Caixa Capital Risc